UK competition regulator made errors in drug pricing case, says Pfizer
The UK competition regulator made errors in a case that led to fines against Pfizer and Flynn Pharma over epilepsy drug pricing, Pfizer has told the UK appeal court. The Competition and...To view the full article, register now.
Already a subscriber? Click here to view full article